Adventris Pharmaceuticals
YC W23 · Active · Adventris makes cancer vaccines
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
| AI | Active | YCS26 | |
| AI | Active | YCS23 | |
| Other | Active | YCW22 | |
| AI | Active | YCW20 | |
| Other | Active | YCS22 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Active | YCW24 | |
| AI | Active | YCW15 | |
| AI | Active | YCS21 | |
| Other | Public | YCS20 | |
| Other | Public | YCW15 |
Also from W23
All of W23About Adventris Pharmaceuticals
Adventris makes cancer vaccines. Our platform solves the problem of targeting poorly immunogenic oncogenes. Our first "off-the-shelf" vaccine targets KRAS, the most common cancer oncogene. In the long run, we envision a world where every adult receives our pan-cancer vaccines annually – preventing the majority of cancer deaths. If you are interested in learning more about our approach to treat and prevent cancer, please reach out to us at contact@adventris.com
- YC batch
- W23 · Winter 2023
- Status, per YC
- Active
- Category
- Other
- Team size
- 7
- Location
- Baltimore, MD, USA
- Checked
- 35m ago
YC tags: Biotech, Healthcare, Therapeutics, Drug discovery, Oncology
Adventris Pharmaceuticals: questions
Which YC batch was Adventris Pharmaceuticals in?
Adventris Pharmaceuticals was in Y Combinator's Winter 2023 batch (W23).
Is Adventris Pharmaceuticals still active?
Y Combinator lists Adventris Pharmaceuticals as active.
Where is Adventris Pharmaceuticals based?
Adventris Pharmaceuticals lists Baltimore, MD, USA as its location on YC's directory.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.